Literature DB >> 17905129

Resolution of hydronephrosis due to massive mesenteric fibromatosis using cyclo-oxygenase 2 inhibitors.

Teik-Ying Ng1, Mei-Due Yang, Yung-Fang Chen, Chao-Hsiang Chang.   

Abstract

Mesenteric fibromatosis is currently a diagnostic and therapeutic challenge. We report a case of mesenteric fibromatosis in a 29-year-old man with a 2-month history of periumbilical fullness who was discovered to have an abdominal mass with hydronephrosis. To the best of our knowledge, we report the first case of hydronephrosis in a mesenteric fibromatosis with Gardner's syndrome, which was successfully treated with a cyclo-oxygenase 2 inhibitor without surgical removal of the mesenteric fibromatosis. The hydronephrosis and mesenteric fibromatosis improved modestly with long-term celecoxib (200 mg twice daily). Our case also highlights the importance of performing a detailed examination in patients with hydronephrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905129     DOI: 10.1016/j.urology.2007.07.025

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Giant mesenteric fibromatosis: Report of a case and review of the literature.

Authors:  Mohammed Khalid Mirza Gari; Salman Yousuf Guraya; Amir Mounir Hussein; Moustafa Mahmoud Nafady Hego
Journal:  World J Gastrointest Surg       Date:  2012-03-27

2.  Giant aggressive mesenteric fibromatosis- a case report.

Authors:  Anandaravi Bn; Jagadish Kumar Cd; Sreejith Ps; Mayur M; Roopa Urs
Journal:  J Clin Diagn Res       Date:  2015-02-01

3.  Mesenteric fibromatosis causing ureteral stenosis.

Authors:  Jae Young Choi; Kyung Mo Kang; Bum Soo Kim; Tae-Hwan Kim
Journal:  Korean J Urol       Date:  2010-07-20

4.  Mesenteric fibromatosis presenting as an irreducible inguinal hernia.

Authors:  Faisal A Alsaif
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

5.  Successful treatment of giant mesenteric fibromatosis with surgery and tamoxifen: case report.

Authors:  Zhixiang Jin; Qi Zhang; Dong Tang; Liuhua Wang; Wei Wang; Minghao Xu; Zhi Li; Daorong Wang
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.